Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04249843
Title Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors MapKure, LLC
Indications

Advanced Solid Tumor

colorectal cancer

lung non-small cell carcinoma

melanoma

Therapies

BGB3245

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST